Note: You are reading this message either because your browser is not standards-compliant, or your browser failed to load our css files.

Covered Companies

Biostar Pharmaceuticals, Inc. - BSPM

There are two ways to treat patients infected with HepB in China. Interferon, a common treatment in the US, is very expensive. Without nationwide health care, Interferon is far too expensive for the average Chinese citizen. Enter Biostar Pharmaceuticals Inc (OTC BB: BSPM)- Biostar is the only Chinese company with an SFDA (Chinese version of our FDA) approval to market an over-the-counter treatment for HepB. It runs just over $1 per day, and has been proven highly effective in clinical trials. BSPM's Xin Aoxing Oleanolic Acid Capsule is the only product on the market that treats chronic hepatitis B disease at a price most Chinese can afford.

Biostar Pharmaceuticals, Inc.
Biostar Pharmaceuticals, Inc. (BSPM)
http://www.biostarpharmaceuticals.com/
Coverage: March 13, 2010 - March 13, 2011
Featured: March 13, 2010

Latest Newsletter Editions

spacer
Sat, Mar 13, 2010 @ 11:03 am
A Global Plague- Prevalent in China Hepatitis B- everyone's heard of it. It kills about 1.2 million people world wide each and every year. Hepatitis B is a virus, and most individuals who become infected with the virus eventually fight it off with their immune system. Once you've recovered from the...

spacer

Latest Blog Entries

spacer

Quote Data

spacer
Last Trade: 3.90 Bid: 3.9000
Last Size: 1,916 Ask: 3.9800
Trade Time: 11:13am Bid x Ask Size: 500x500
Change: down arrow -0.1400 (-3.47%) Day's Range: 3.90 - 4.07
Prev Close: 4.0400 52wk Range: 0.00 - 0.00
Open: 4.0600 P/E (ttm): N/A
Volume: 58,790 EPS (ttm): 0.00
spacer
[Chart]

Business Summary

spacer
Biostar Pharmaceuticals, Inc., through its wholly owned subsidiary in China, develops, manufactures and markets pharmaceutical and medical nutrient products for a variety of diseases and conditions. The Company's most popular product is its Xin Aoxing Oleanolic Acid Capsule, an over-the-counter ("OTC") medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. In addition to its hepatitis product, Biostar manufactures two broad-based OTC products, two prescription-based pharmaceuticals and thirteen nutrients. The Company has adopted international standards and is in the process of applying for two patents.

Disclosure

spacer
Myself and my associates started accumulating this a week ago. As a group, we own about 17,000 shares, purchased in the open market, from $3.50 to nearly $4. We'll buy and sell them anytime we want, and you might view this as a conflict of interest.

Recent News Headlines

spacer
Tue, 9 Mar 2010 15:31:45 Etc/GMT
Sun, 7 Mar 2010 10:59:40 Etc/GMT
Wed, 3 Mar 2010 13:00:00 Etc/GMT
Mon, 1 Mar 2010 18:54:16 Etc/GMT
Mon, 1 Mar 2010 13:00:00 Etc/GMT
Thu, 25 Feb 2010 17:02:50 Etc/GMT
Thu, 25 Feb 2010 13:00:00 Etc/GMT
Thu, 18 Feb 2010 14:30:00 Etc/GMT
Tue, 16 Feb 2010 08:36:41 Etc/GMT
Thu, 28 Jan 2010 18:27:09 Etc/GMT
Thu, 28 Jan 2010 15:24:10 Etc/GMT
Thu, 28 Jan 2010 13:00:00 Etc/GMT
Tue, 5 Jan 2010 20:58:42 Etc/GMT
Mon, 4 Jan 2010 13:00:00 Etc/GMT
Wed, 30 Dec 2009 20:04:23 Etc/GMT
Tue, 29 Dec 2009 13:00:00 Etc/GMT
Thu, 24 Dec 2009 15:32:25 Etc/GMT
Wed, 16 Dec 2009 19:50:25 Etc/GMT
Wed, 16 Dec 2009 13:00:00 Etc/GMT
Thu, 10 Dec 2009 11:00:30 Etc/GMT
Daily Blog
RSS Subscribe

China Energy Recovery, Inc.
Newsletter
Editions
RSS Subscribe

To subscribe to our newsletter, please enter your email address below.

Share
Market Summary
Dow 10672.08 +29.93 (+0.28%)
Nasdaq 2373.95 +11.74 (+0.50%)
Russell 2K 676.62 +2.21 (+0.33%)
S&P 500 1156.50 +5.99 (+0.52%)
S&P 100 528.91 +2.52 (+0.48%)
Quotes are delayed 20 minutes.

Add to Google

China Stocks and Penny Stocks - Discover Tomorrow's Winners Today

© 2010 OTC Journal